Karl-Anton Kreuzer Selected Research

Thrombopoietin (c-mpl Ligand)

1/2017

Thrombopoietin mimetics for patients with myelodysplastic syndromes.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Karl-Anton Kreuzer Research Topics

Disease

23	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 01/2022 - 01/2010
14	Neoplasms (Cancer) 01/2021 - 11/2009
11	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 03/2011 - 01/2002
7	Neutropenia 01/2020 - 03/2014
7	Infections 06/2019 - 03/2002
6	Philadelphia Chromosome 09/2012 - 10/2002
5	Residual Neoplasm 12/2021 - 10/2017
5	Leukemia 04/2016 - 10/2002
4	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 12/2018 - 07/2012
4	Lymphoma (Lymphomas) 04/2016 - 10/2011
3	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 01/2017 - 02/2016
3	Body Weight (Weight, Body) 01/2011 - 01/2004
2	Hemorrhage 01/2022 - 01/2017
2	Pneumonia (Pneumonitis) 01/2022 - 04/2016
2	Exanthema (Rash) 01/2022 - 10/2002
2	Squamous Cell Carcinoma (Epidermoid Carcinoma) 01/2020 - 04/2003
2	Thrombocytopenia (Thrombopenia) 01/2017 - 04/2016
2	Carcinoma (Carcinomatosis) 03/2009 - 04/2003
1	Myocardial Infarction 01/2022
1	Basal Cell Carcinoma (Rodent Ulcer) 01/2022
1	Atrial Fibrillation 01/2022
1	Septic Shock (Toxic Shock Syndrome) 01/2020
1	Sepsis (Septicemia) 01/2020
1	Disease Progression 06/2019
1	Acute Promyelocytic Leukemia 02/2018
1	Cardiotoxicity 01/2018
1	Leukoencephalopathies 10/2017
1	Gastrointestinal Diseases (Functional Gastrointestinal Disorders) 10/2017
1	Febrile Neutropenia 04/2016
1	Refractory Anemia with Excess of Blasts (RAEM) 04/2016
1	Systemic Inflammatory Response Syndrome (Sepsis Syndrome) 01/2016
1	Critical Illness (Critically Ill) 01/2016
1	Myeloid Sarcoma (Chloroma) 06/2014
1	Mycoses (Diseases, Fungus) 02/2014
1	Oral Candidiasis (Thrush) 02/2014

Drug/Important Bio-Agent (IBA)

11	Imatinib Mesylate (Gleevec)FDA Link 03/2011 - 01/2002
8	obinutuzumabIBA 01/2022 - 03/2014
7	Bendamustine Hydrochloride FDA Link 01/2022 - 09/2012
7	Rituximab (Mabthera)FDA Link 02/2020 - 09/2012
6	venetoclaxIBA 12/2021 - 01/2018
5	Pharmaceutical PreparationsIBA 01/2022 - 10/2002
5	ibrutinibIBA 01/2022 - 03/2018
4	Tyrosine Kinase InhibitorsIBA 02/2011 - 08/2003
4	Messenger RNA (mRNA)IBA 01/2010 - 08/2003
3	Cyclophosphamide (Cytoxan)FDA LinkGeneric 02/2020 - 01/2016
3	fludarabineIBA 02/2020 - 01/2016
3	Chlorambucil (Leukeran)FDA Link 01/2020 - 03/2014
3	Cytarabine (Cytosar-U)FDA LinkGeneric 12/2018 - 06/2014
3	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 11/2012 - 07/2010
3	beta CateninIBA 04/2010 - 03/2009
3	Glycoproteins (Glycoprotein)IBA 11/2009 - 01/2002
2	ofatumumab FDA Link 01/2021 - 03/2018
2	idelalisibIBA 01/2020 - 03/2018
2	Lenalidomide (CC 5013)FDA Link 10/2017 - 09/2016
2	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 02/2016 - 10/2003
2	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 03/2015 - 11/2012
2	Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA 11/2012 - 07/2010
2	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 10/2011 - 01/2011
2	Nitric Oxide (Nitrogen Monoxide)FDA Link 10/2011 - 01/2011
2	Antineoplastic Agents (Antineoplastics)IBA 10/2011 - 01/2011
2	nitroxy-butyl-acetylsalicylic acidIBA 10/2011 - 01/2011
2	CGP049090IBA 04/2010 - 03/2009
2	bcr-abl Fusion ProteinsIBA 03/2005 - 01/2002
2	Phosphotransferases (Kinase)IBA 03/2005 - 10/2002
2	AcidsIBA 08/2003 - 01/2002
1	AnticoagulantsIBA 01/2022
1	Cytochrome P-450 CYP3AIBA 01/2022
1	pipoxolan (BR 18)IBA 02/2020
1	Mitoxantrone (Novantrone)FDA LinkGeneric 12/2018
1	Tretinoin (Retinoic Acid)FDA LinkGeneric 02/2018
1	AnthracyclinesIBA 02/2018
1	PanobinostatIBA 01/2018
1	Genetic Markers (Genetic Marker)IBA 10/2017
1	Thrombopoietin (c-mpl Ligand)IBA 01/2017
1	Azacitidine (5 Azacytidine)FDA Link 04/2016
1	ON 01910IBA 04/2016
1	Decitabine FDA Link 04/2016
1	Colony-Stimulating Factors (Colony Stimulating Factor)IBA 02/2016
1	HematinicsIBA 02/2016
1	Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA 02/2016
1	Oxygen (Dioxygen)IBA 01/2016
1	trichostatin A (A 300)IBA 08/2014
1	Histones (Histone)IBA 08/2014
1	posaconazole FDA Link 02/2014
1	Sorafenib (BAY 43-9006)FDA Link 09/2013
1	DNA (Deoxyribonucleic Acid)IBA 06/2013

Therapy/Procedure

17	Therapeutics 01/2019 - 01/2002
8	Drug Therapy (Chemotherapy) 01/2022 - 04/2003
2	Aftercare (After-Treatment) 01/2018 - 01/2016
2	Platelet Transfusion (Blood Platelet Transfusions) 01/2017 - 02/2016
2	Radiotherapy 06/2014 - 03/2005
2	Stem Cell Transplantation 09/2012 - 10/2011
2	Hematopoietic Stem Cell Mobilization 03/2011 - 10/2003
1	Duration of Therapy 03/2018
1	Erythrocyte Transfusion 02/2016
1	Blood Transfusion (Blood Transfusions) 02/2016
1	Renal Dialysis (Hemodialysis) 01/2016
1	Artificial Respiration (Mechanical Ventilation) 01/2016
1	Critical Care (Surgical Intensive Care) 01/2016
1	Consolidation Chemotherapy 06/2014